As of May 30, 2026, the three largest insider holders of XENE are Mohammad Azab (Director, 74.22K shares), Dawn Svoronos (Director, 25.00K shares), Gary Patou (Director, 23.57K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Gary Patou | - | 23,573 | 0 | 22 Nov, 2024 |
| Mohammad Azab | - | 74,225 | 0 | 20 Dec, 2023 |
| Dawn Svoronos | - | 25,000 | 0 | 24 Aug, 2023 |
| Ian Mortimer | President Ceo | 19,923 | 0 | 13 Mar, 2026 |
| Sherrington Robin | Evp, Strategy Innovation | 8,398 | 0 | 08 Mar, 2024 |
| Simon N. Pimstone | Ceo | 6,000 | 0 | 01 Jun, 2023 |
| Steven Gannon | - | 7,141 | 0 | 06 Jun, 2025 |
| James R. Empfield | Evp, Drug Discovery | 10,000 | 0 | 16 Aug, 2022 |
| Andrea Difabio | Chief Legal Officer | 7,301 | 0 | 13 Mar, 2026 |
| Seggern Christopher Von | Chief Commercial Officer | 4,000 | 0 | 07 Dec, 2021 |
| Christopher John Kenney | Chief Medical Officer | 7,069 | 0 | 13 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Christopher John Kenney | Common Shares | A | 3,750 | - | 8,479 | D | M |
| 12 Mar, 2026 | Andrea Difabio | Common Shares | A | 3,750 | - | 8,643 | D | M |
| 12 Mar, 2026 | Ian Mortimer | Common Shares | A | 12,500 | - | 27,231 | D | M |
| 13 Mar, 2026 | Andrea Difabio | Common Shares | D | 1,342 | $55.23 | 7,301 | D | S |
| 13 Mar, 2026 | Christopher John Kenney | Common Shares | D | 1,410 | $55.23 | 7,069 | D | S |
| 13 Mar, 2026 | Ian Mortimer | Common Shares | D | 7,308 | $55.23 | 19,923 | D | S |
| 12 Mar, 2026 | Andrea Difabio | Restricted Share Units | D | 3,750 | $0.00 | 11,250 | D | M |
| 12 Mar, 2026 | Christopher John Kenney | Restricted Share Units | D | 3,750 | $0.00 | 11,250 | D | M |
| 12 Mar, 2026 | Ian Mortimer | Restricted Share Units | D | 12,500 | $0.00 | 37,500 | D | M |
| 09 Mar, 2026 | Christopher John Kenney | Common Shares | A | 7,500 | - | 7,500 | D | M |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | A | 75,000 | $8.40 | 81,000 | D | M |
| 09 Mar, 2026 | Andrea Difabio | Common Shares | A | 7,500 | - | 7,500 | D | M |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | D | 21,791 | $58.81 | 59,209 | D | S |
| 10 Mar, 2026 | Andrea Difabio | Common Shares | D | 2,607 | $60.11 | 4,893 | D | S |
| 10 Mar, 2026 | Christopher John Kenney | Common Shares | D | 2,771 | $60.11 | 4,729 | D | S |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | D | 31,694 | $59.88 | 27,515 | D | S |
| 09 Mar, 2026 | Andrea Difabio | Performance Share Units | A | 7,500 | $0.00 | 7,500 | D | A |
| 09 Mar, 2026 | Christopher John Kenney | Performance Share Units | A | 7,500 | $0.00 | 7,500 | D | A |
| 09 Mar, 2026 | Ian Mortimer | Common Shares | D | 21,515 | $60.49 | 6,000 | D | S |
| 09 Mar, 2026 | Christopher John Kenney | Performance Share Units | D | 7,500 | $0.00 | 0 | D | M |